Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE Trial.

Publication date: Jul 19, 2024

Children with human immunodeficiency virus (HIV, CWH) are at high risk of tuberculosis (TB) and face poor outcomes, despite antiretroviral therapy (ART). We evaluated outcomes in CWH and children not living with HIV treated for nonsevere TB in the SHINE trial. SHINE was a randomized trial that enrolled children aged

Concepts Keywords
Hiv Adolescent
Immunodeficiency adverse events
Shine Anti-HIV Agents
Therapy Anti-HIV Agents
Tuberculosis Antitubercular Agents
Antitubercular Agents
CD4 Lymphocyte Count
Child
Child, Preschool
children with HIV
Female
HIV Infections
Hospitalization
Humans
Infant
Male
mortality
Recurrence
Treatment Outcome
Tuberculosis
tuberculosis
Viral Load
viral suppression

Semantics

Type Source Name
disease VO Human immunodeficiency virus
disease MESH Tuberculosis
pathway KEGG Tuberculosis
disease MESH HIV Infections

Original Article

(Visited 5 times, 1 visits today)